Manufacturing and R&D Center

Ginsenoside Manufacturing and R&D Center
Ginsenoside Manufacturing and R&D Center

The fungal fermentation method developed by this company can transform raw materials rich in the ginsenosides Rb1, Rg1, and Rb3 into "rare ginsenosides" via fermentation. We use our functional group fungal bioconversion method to produce rare ginseng saponins and our low-acid degradation method to produce Rh2 and Rg3 high-value saponins. In particular, the functional group fungal bioconversion method is currently the world's only patented technology able to produce large quantities of rare ginseng saponins; this technology combines such key technologies as extraction from alternative raw materials, selection of fermentation fungi, solid fermentation, high-efficiency column chromatography, and liquid phase centrifugal chromatography, and yields large amounts of various ginsenosides. These ginsenosides can be widely used in beverages, foods, nutriceutical foods, prescription medicines, injected drugs, and new drug development, and have tremendous economic value.